January 28, 2018 / 11:09 PM / 8 months ago

BRIEF-Botanix Pharmaceuticals Updates On Phase 1b Study Of BTX 1503

Jan 29 (Reuters) - Botanix Pharmaceuticals Ltd:

* ‍ PHASE 1B STUDY OF BTX 1503 IN PATIENTS WITH MODERATE TO SEVERE ACNE MET ALL DESIGNATED ENDPOINTS ​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below